Infant exposure to dioxin-like compounds in breast milk

Environmental Health Perspectives

Volumn 110, Issue 6, 2002, Pages

  Lorber, Matthew ^a   Phillips, Linda ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b VERSAR INC   (United States)

Author keywords

Breast milk; Dioxin like compounds; Dioxins; Furans; Infant exposure; Pharmacokinetic modeling

Indexed keywords

DIOXIN; LIPID;

ARTICLE; ARTIFICIAL MILK; BIRTH WEIGHT; BODY BURDEN; BREAST FEEDING; BREAST MILK; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; INFANT; PREDICTION; PRIORITY JOURNAL; TOXICOKINETICS; VALIDATION PROCESS;

EID: 0036077556     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.021100325     Document Type: Article

References (29)

1. Health risk assessment for newborns exposed to organochlorine compounds through breast feeding
2. Dietary exposure to polychlorinated biphenyls and dioxins from infancy until adulthood: A comparison between breast-feeding, toddler, and long-term exposure
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition
4. Methodology for characterizing distributions of incremental body burdens of 2,3,7,8-TCDD and DDE from breast milk in North American nursing infants
5. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife
6. A model to evaluate past exposure to 2,3,7,8-TCDD
7. Estimation of dioxin and furan elimination rates with a pharmacokinetic model
8. Pharmacokinetic model of dioxin and furan levels in adipose tissue from sawmill work involving chlorophenate fungicides
9. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissues
10. Modeling of the toxico-kinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs
11. Pharmacokinetics of TCDD in veterans of operation Ranch Hand: 10-year follow up
12. Elimination of polychlorinated dibenzo-p-dioxins in occupationally exposed persons
13. Bioconcentration potential of (BCP) of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) in terrestrial organisms including humans
14. Infant exposure assessment for breast milk dioxins and furans derived from waste incineration emissions
15. Disposition of octachlorodibenzo-p-dioxin (OCDD) in male rats
16. POP accumulation in infants during breast-feeding
17. Plasma polychlorinated biphenyl levels in Dutch preschool children either breast-fed or formula-fed during infancy
18. Concentrations of PCDDs, PCDFs and coplanar PCBs in blood fat of a breast-fed and a formula-fed infant
19. Changes in blood lipid concentration of PCDDs, PCDFs, and coplanar PCBs in a breast-fed and a formula-fed infant in the second year of life
20. Time course of PCDD/PCDF/PCB concentrations in breast-feeding mothers and their infants
21. Draft Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds
22. Fertility, Family Planning, and Women's Health: New Data from the 1995 National Survey of Family Growth
23. American Academy of Pediatrics: Breastfeeding and the use of human milk
24. Time trends in human dietary exposure to PCDDs, PCDFs and PCBs in the UK
25. Dioxin, and furan levels in Ontario Great Lake anglers
26. Great Lakes Consortium. Body burden levels of dioxin, furans, and PCBs among frequent consumers of Great Lakes sport fish
27. Great Lakes Consortium. Profiles of Great Lakes critical pollutants: A sentinel analysis of human blood and urine